Profiel
Dr. Nicholas M.
Dean is a Director & Chief Scientific Officer at Microlin Bio, Inc. He is on the Board of Directors at Microlin Bio, Inc.
Dr. Dean was previously employed as a Director & Chief Scientific Officer by Excaliard Pharmaceuticals, Inc. and Vice President-Functional Genomics & Oncology by Isis Pharmaceuticals, Inc.
He received his undergraduate degree from The University of Wales and a doctorate degree from The University of Wales.
Eerdere bekende functies van Nicholas M. Dean
| Bedrijven | Functie | Einde |
|---|---|---|
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Oprichter | 01-03-2012 |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Hoofd Techniek/Wetenschap/O&O | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Nicholas M. Dean
| The University of Wales | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |
